• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症溃疡性结肠炎的区域胃肠道转运时间

Regional gastrointestinal transit times in severe ulcerative colitis.

作者信息

Haase A M, Gregersen T, Christensen L A, Agnholt J, Dahlerup J F, Schlageter V, Krogh K

机构信息

Neurogastroenterology Unit, Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Motilis Medica SA, Lausanne, Switzerland.

出版信息

Neurogastroenterol Motil. 2016 Feb;28(2):217-24. doi: 10.1111/nmo.12713. Epub 2016 Jan 4.

DOI:10.1111/nmo.12713
PMID:26729638
Abstract

BACKGROUND

Gastrointestinal (GI) dysmotility may present secondary to inflammatory bowel disease. The main aim of this study was to investigate GI motility in ulcerative colitis (UC) patients during severe disease activity.

METHODS

Twenty patients with severe UC were studied with a novel telemetric capsule system (3D-Transit) designed for minimally invasive, ambulatory assessment of total and regional GI transit times. Ten patients were available for follow-up during remission. Data were compared to those of 20 healthy subjects (HS).

KEY RESULTS

Total GI transit time was significantly longer in patients with severe UC (median 44.5 h [range 9.9-102.7 h]) than in HS (median 27.6 h [range 9.6-56.4 h]) (p = 0.032). Additionally, during severe UC, transit time was prolonged through the proximal colon (p = 0.003) and there were strong trends toward longer than normal small intestinal transit time (HS: median 4.9 h [range 3.4-8.3 h] vs severe UC patients: median 5.9 h [range 3.9-11.9 h]; p = 0.053) and colorectal transit times (HS: median 18.2 h [range 1.5-43.7] vs severe UC patients: median 34.9 h [range 0.4-90.9 h]; p = 0.056). Our data further indicate that total GI and colorectal transit times may be prolonged in UC during early remission.

CONCLUSIONS & INFERENCES: Total GI transit times are significantly prolonged during severe UC.

摘要

背景

胃肠道动力障碍可能继发于炎症性肠病。本研究的主要目的是调查溃疡性结肠炎(UC)患者在疾病严重活动期的胃肠道动力。

方法

采用一种新型遥测胶囊系统(3D-Transit)对20例重度UC患者进行研究,该系统设计用于微创、动态评估全胃肠道和区域胃肠道转运时间。10例患者在缓解期可进行随访。将数据与20名健康受试者(HS)的数据进行比较。

主要结果

重度UC患者的全胃肠道转运时间(中位数44.5小时[范围9.9-102.7小时])显著长于HS(中位数27.6小时[范围9.6-56.4小时])(p = 0.032)。此外,在重度UC期间,近端结肠的转运时间延长(p = 0.003),小肠转运时间和结直肠转运时间有长于正常的强烈趋势(HS:中位数4.9小时[范围3.4-8.3小时] vs重度UC患者:中位数5.9小时[范围3.9-11.9小时];p = 0.053)以及(HS:中位数18.2小时[范围1.5-43.7] vs重度UC患者:中位数34.9小时[范围0.4-90.9小时];p = 0.056)。我们的数据进一步表明,UC患者在早期缓解期全胃肠道和结直肠转运时间可能延长。

结论与推论

重度UC期间全胃肠道转运时间显著延长。

相似文献

1
Regional gastrointestinal transit times in severe ulcerative colitis.重症溃疡性结肠炎的区域胃肠道转运时间
Neurogastroenterol Motil. 2016 Feb;28(2):217-24. doi: 10.1111/nmo.12713. Epub 2016 Jan 4.
2
Assessment of Small Intestinal Transit Times in Ulcerative Colitis and Crohn's Disease Patients with Different Disease Activity Using Video Capsule Endoscopy.使用视频胶囊内镜评估不同疾病活动度的溃疡性结肠炎和克罗恩病患者的小肠转运时间
AAPS PharmSciTech. 2017 Feb;18(2):404-409. doi: 10.1208/s12249-016-0521-3. Epub 2016 Mar 31.
3
Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol.采用无线动力胶囊对 215 名健康志愿者进行区域性胃肠道转运和 pH 值研究:年龄、性别、研究国家和测试方案的影响。
Aliment Pharmacol Ther. 2015 Sep;42(6):761-72. doi: 10.1111/apt.13329. Epub 2015 Jul 29.
4
Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients.溃疡性结肠炎患者细胞因子、氧化应激、胃肠动力与细菌过度生长的关系
J Crohns Colitis. 2014 Aug;8(8):859-65. doi: 10.1016/j.crohns.2014.01.007. Epub 2014 Jan 21.
5
Pilot study trialling a new ambulatory method for the clinical assessment of regional gastrointestinal transit using multiple electromagnetic capsules.一项试点研究,试用一种新的动态方法,使用多个电磁胶囊对区域胃肠道转运进行临床评估。
Neurogastroenterol Motil. 2014 Dec;26(12):1783-91. doi: 10.1111/nmo.12461. Epub 2014 Oct 27.
6
Effects of fiber intake on intestinal pH, transit, and predicted oral mesalamine delivery in patients with ulcerative colitis.膳食纤维摄入对溃疡性结肠炎患者肠道 pH 值、转运和预测的口服美沙拉嗪递送的影响。
J Gastroenterol Hepatol. 2021 Jun;36(6):1580-1589. doi: 10.1111/jgh.15311. Epub 2020 Nov 22.
7
A Simple 1-Day Colon Capsule Endoscopy Procedure Demonstrated to be a Highly Acceptable Monitoring Tool for Ulcerative Colitis.简单的 1 日胶囊内镜检查程序,被证明是溃疡性结肠炎的一种高度可接受的监测工具。
Inflamm Bowel Dis. 2018 Oct 12;24(11):2404-2412. doi: 10.1093/ibd/izy125.
8
Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system.采用电磁胶囊跟踪系统对结肠动力进行门诊评估。
Neurogastroenterol Motil. 2019 Feb;31(2):e13451. doi: 10.1111/nmo.13451. Epub 2018 Aug 20.
9
Normative values for region-specific colonic and gastrointestinal transit times in 111 healthy volunteers using the 3D-Transit electromagnet tracking system: Influence of age, gender, and body mass index.使用 3D-Transit 电磁跟踪系统测量 111 例健康志愿者的特定区域结肠和胃肠道传输时间的正常值:年龄、性别和体重指数的影响。
Neurogastroenterol Motil. 2020 Feb;32(2):e13734. doi: 10.1111/nmo.13734. Epub 2019 Sep 29.
10
Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.小肠细菌过度生长时小肠转运时间会延迟。
J Clin Gastroenterol. 2015 Aug;49(7):571-6. doi: 10.1097/MCG.0000000000000257.

引用本文的文献

1
Constipation in Ulcerative Colitis: An Underestimated Problem.溃疡性结肠炎中的便秘:一个被低估的问题。
J Clin Med. 2025 Aug 1;14(15):5428. doi: 10.3390/jcm14155428.
2
Targeted oral delivery of microencapsulated TNF-α siRNA in an experimental model of colitis.在结肠炎实验模型中微囊化肿瘤坏死因子-α 小干扰RNA的靶向口服递送
Drug Deliv Transl Res. 2025 Aug 6. doi: 10.1007/s13346-025-01936-3.
3
Glial cell line-derived neurotrophic factor improves impaired colonic motility in experimental colitis mice through connexin 43.胶质细胞源性神经营养因子通过连接蛋白43改善实验性结肠炎小鼠受损的结肠动力。
World J Gastroenterol. 2025 Feb 28;31(8):100069. doi: 10.3748/wjg.v31.i8.100069.
4
The Use of Tissue Concentrations of Biological and Small-Molecule Therapies in Clinical Studies of Inflammatory Bowel Diseases.生物和小分子疗法的组织浓度在炎症性肠病临床研究中的应用
Pharmaceutics. 2024 Nov 22;16(12):1497. doi: 10.3390/pharmaceutics16121497.
5
Bioresponsive and transformable coacervate actuated by intestinal peristalsis for targeted treatment of intestinal bleeding and inflammation.由肠道蠕动驱动的生物响应性和可转化凝聚层用于肠道出血和炎症的靶向治疗。
Bioact Mater. 2024 Aug 28;41:627-639. doi: 10.1016/j.bioactmat.2024.08.020. eCollection 2024 Nov.
6
Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time.肠道微生物群对体外传输时间变化的反应是由微生物生长速度、营养利用效率和对体内传输时间的适应介导的。
Microbiome. 2023 Nov 6;11(1):240. doi: 10.1186/s40168-023-01691-y.
7
Advancing human gut microbiota research by considering gut transit time.通过考虑肠道传输时间来推进人类肠道微生物组研究。
Gut. 2023 Jan;72(1):180-191. doi: 10.1136/gutjnl-2022-328166. Epub 2022 Sep 28.
8
Bridging Efficacy of Tofacitinib Immediate-Release to Extended-Release Formulations for Treatment of Ulcerative Colitis: Application of a Model-Informed Drug Development Approach.托法替布速释制剂到缓释制剂桥接治疗溃疡性结肠炎的疗效:模型指导药物开发方法的应用。
Clin Pharmacol Drug Dev. 2022 Aug;11(8):976-986. doi: 10.1002/cpdd.1106. Epub 2022 May 13.
9
In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications.用于评估结肠靶向药物产品的体外方法及其应用的行业观点。
Pharmaceutics. 2022 Jan 26;14(2):291. doi: 10.3390/pharmaceutics14020291.
10
Constipation in ulcerative colitis: pathophysiology and practical management.溃疡性结肠炎中的便秘:病理生理学与实际管理
Frontline Gastroenterol. 2020 Aug 26;12(6):493-499. doi: 10.1136/flgastro-2020-101566. eCollection 2021.